PTGS2 and eosinophilia-myalgia syndrome: Additionally, steroid perturbation promotes endometriotic lesion formation by activating MMPs and angiogenesis.[1] Therefore, regulating the levels of estrogen and progesterone and their receptors, reducing the secretion of COX-2, and further reducing prostaglandin production are therapeutic strategies for reducing pain in patients with EMs.